Loading…

Oseltamivir and Its Active Metabolite Cross the Placenta at Significant Levels

Saved in:

Bibliographic Details
Published in:	Clinical infectious diseases 2012-06, Vol.54 (11), p.1676-1677
Main Authors:	Meijer, Wouter J., Bruinse, Hein W., van den Broek, Marcel P. H., Kromdijk, Wiete, Wensing, Annemarie M. J.
Format:	Article
Language:	English
Subjects:	Adult Antiviral Agents - administration & dosage Antiviral Agents - pharmacokinetics Blood Blood plasma Carboxylates Chromatography, Liquid Correspondence Dosage Female Fetal Blood - chemistry H1N1 subtype influenza A virus Humans Infections Influenza A virus Influenza, Human - drug therapy Oseltamivir - administration & dosage Oseltamivir - pharmacokinetics Placenta Placenta - physiology Plasma - chemistry Pregnancy Pregnancy Complications, Infectious - drug therapy Tandem Mass Spectrometry Umbilical cord
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c312t-4e1cb3ee1ac43de1c6d346c6477dd661d75ec048a78ee3fb3fb6ea445c02e0ed3
cites	cdi_FETCH-LOGICAL-c312t-4e1cb3ee1ac43de1c6d346c6477dd661d75ec048a78ee3fb3fb6ea445c02e0ed3
container_end_page	1677
container_issue	11
container_start_page	1676
container_title	Clinical infectious diseases
container_volume	54
creator	Meijer, Wouter J. Bruinse, Hein W. van den Broek, Marcel P. H. Kromdijk, Wiete Wensing, Annemarie M. J.
description
doi_str_mv	10.1093/cid/cis265
format	article
fullrecord	<record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_cid_cis265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>23212791</jstor_id><sourcerecordid>23212791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-4e1cb3ee1ac43de1c6d346c6477dd661d75ec048a78ee3fb3fb6ea445c02e0ed3</originalsourceid><addsrcrecordid>eNpFkEtLw0AQgBdRbK1evCt7FqL7zuZYio9CtIJ6DpvdiW5J05JdA_57t8QHzDAzzMcwfAidU3JNScFvrHcpA1PyAE2p5HmmZEEPU0-kzoTmeoJOQlgTQqkm8hhNGBOKFEpP0dMqQBvNxg--x6ZzeBkDntvoB8CPEE29bX0EvOi3IeD4Afi5NRa6aLCJ-MW_d77x1nQRlzBAG07RUWPaAGc_dYbe7m5fFw9ZubpfLuZlZjllMRNAbc0BqLGCuzQox4WySuS5c0pRl0uwRGiTawDe1CkUGCGkJQwIOD5DV-Ndu3-sh6ba9X5j-q-KkmovpUpSqlFKgi9HePdZb8D9ob8WEnAxAusQt_3_njPK8oLybyktaK8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Oseltamivir and Its Active Metabolite Cross the Placenta at Significant Levels</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford Journals Online</source><creator>Meijer, Wouter J. ; Bruinse, Hein W. ; van den Broek, Marcel P. H. ; Kromdijk, Wiete ; Wensing, Annemarie M. J.</creator><creatorcontrib>Meijer, Wouter J. ; Bruinse, Hein W. ; van den Broek, Marcel P. H. ; Kromdijk, Wiete ; Wensing, Annemarie M. J.</creatorcontrib><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/cis265</identifier><identifier>PMID: 22460968</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Adult ; Antiviral Agents - administration & dosage ; Antiviral Agents - pharmacokinetics ; Blood ; Blood plasma ; Carboxylates ; Chromatography, Liquid ; Correspondence ; Dosage ; Female ; Fetal Blood - chemistry ; H1N1 subtype influenza A virus ; Humans ; Infections ; Influenza A virus ; Influenza, Human - drug therapy ; Oseltamivir - administration & dosage ; Oseltamivir - pharmacokinetics ; Placenta ; Placenta - physiology ; Plasma - chemistry ; Pregnancy ; Pregnancy Complications, Infectious - drug therapy ; Tandem Mass Spectrometry ; Umbilical cord</subject><ispartof>Clinical infectious diseases, 2012-06, Vol.54 (11), p.1676-1677</ispartof><rights>Copyright © 2012 Oxford University Press on behalf of the Infectious Diseases Society of America</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-4e1cb3ee1ac43de1c6d346c6477dd661d75ec048a78ee3fb3fb6ea445c02e0ed3</citedby><cites>FETCH-LOGICAL-c312t-4e1cb3ee1ac43de1c6d346c6477dd661d75ec048a78ee3fb3fb6ea445c02e0ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/23212791$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/23212791$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22460968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meijer, Wouter J.</creatorcontrib><creatorcontrib>Bruinse, Hein W.</creatorcontrib><creatorcontrib>van den Broek, Marcel P. H.</creatorcontrib><creatorcontrib>Kromdijk, Wiete</creatorcontrib><creatorcontrib>Wensing, Annemarie M. J.</creatorcontrib><title>Oseltamivir and Its Active Metabolite Cross the Placenta at Significant Levels</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><subject>Adult</subject><subject>Antiviral Agents - administration & dosage</subject><subject>Antiviral Agents - pharmacokinetics</subject><subject>Blood</subject><subject>Blood plasma</subject><subject>Carboxylates</subject><subject>Chromatography, Liquid</subject><subject>Correspondence</subject><subject>Dosage</subject><subject>Female</subject><subject>Fetal Blood - chemistry</subject><subject>H1N1 subtype influenza A virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Influenza A virus</subject><subject>Influenza, Human - drug therapy</subject><subject>Oseltamivir - administration & dosage</subject><subject>Oseltamivir - pharmacokinetics</subject><subject>Placenta</subject><subject>Placenta - physiology</subject><subject>Plasma - chemistry</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - drug therapy</subject><subject>Tandem Mass Spectrometry</subject><subject>Umbilical cord</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpFkEtLw0AQgBdRbK1evCt7FqL7zuZYio9CtIJ6DpvdiW5J05JdA_57t8QHzDAzzMcwfAidU3JNScFvrHcpA1PyAE2p5HmmZEEPU0-kzoTmeoJOQlgTQqkm8hhNGBOKFEpP0dMqQBvNxg--x6ZzeBkDntvoB8CPEE29bX0EvOi3IeD4Afi5NRa6aLCJ-MW_d77x1nQRlzBAG07RUWPaAGc_dYbe7m5fFw9ZubpfLuZlZjllMRNAbc0BqLGCuzQox4WySuS5c0pRl0uwRGiTawDe1CkUGCGkJQwIOD5DV-Ndu3-sh6ba9X5j-q-KkmovpUpSqlFKgi9HePdZb8D9ob8WEnAxAusQt_3_njPK8oLybyktaK8</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Meijer, Wouter J.</creator><creator>Bruinse, Hein W.</creator><creator>van den Broek, Marcel P. H.</creator><creator>Kromdijk, Wiete</creator><creator>Wensing, Annemarie M. J.</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20120601</creationdate><title>Oseltamivir and Its Active Metabolite Cross the Placenta at Significant Levels</title><author>Meijer, Wouter J. ; Bruinse, Hein W. ; van den Broek, Marcel P. H. ; Kromdijk, Wiete ; Wensing, Annemarie M. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-4e1cb3ee1ac43de1c6d346c6477dd661d75ec048a78ee3fb3fb6ea445c02e0ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Antiviral Agents - administration & dosage</topic><topic>Antiviral Agents - pharmacokinetics</topic><topic>Blood</topic><topic>Blood plasma</topic><topic>Carboxylates</topic><topic>Chromatography, Liquid</topic><topic>Correspondence</topic><topic>Dosage</topic><topic>Female</topic><topic>Fetal Blood - chemistry</topic><topic>H1N1 subtype influenza A virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Influenza A virus</topic><topic>Influenza, Human - drug therapy</topic><topic>Oseltamivir - administration & dosage</topic><topic>Oseltamivir - pharmacokinetics</topic><topic>Placenta</topic><topic>Placenta - physiology</topic><topic>Plasma - chemistry</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - drug therapy</topic><topic>Tandem Mass Spectrometry</topic><topic>Umbilical cord</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meijer, Wouter J.</creatorcontrib><creatorcontrib>Bruinse, Hein W.</creatorcontrib><creatorcontrib>van den Broek, Marcel P. H.</creatorcontrib><creatorcontrib>Kromdijk, Wiete</creatorcontrib><creatorcontrib>Wensing, Annemarie M. J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meijer, Wouter J.</au><au>Bruinse, Hein W.</au><au>van den Broek, Marcel P. H.</au><au>Kromdijk, Wiete</au><au>Wensing, Annemarie M. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oseltamivir and Its Active Metabolite Cross the Placenta at Significant Levels</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>54</volume><issue>11</issue><spage>1676</spage><epage>1677</epage><pages>1676-1677</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><cop>United States</cop><pub>Oxford University Press</pub><pmid>22460968</pmid><doi>10.1093/cid/cis265</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1058-4838
ispartof	Clinical infectious diseases, 2012-06, Vol.54 (11), p.1676-1677
issn	1058-4838 1537-6591
language	eng
recordid	cdi_crossref_primary_10_1093_cid_cis265
source	JSTOR Archival Journals and Primary Sources Collection; Oxford Journals Online
subjects	Adult Antiviral Agents - administration & dosage Antiviral Agents - pharmacokinetics Blood Blood plasma Carboxylates Chromatography, Liquid Correspondence Dosage Female Fetal Blood - chemistry H1N1 subtype influenza A virus Humans Infections Influenza A virus Influenza, Human - drug therapy Oseltamivir - administration & dosage Oseltamivir - pharmacokinetics Placenta Placenta - physiology Plasma - chemistry Pregnancy Pregnancy Complications, Infectious - drug therapy Tandem Mass Spectrometry Umbilical cord
title	Oseltamivir and Its Active Metabolite Cross the Placenta at Significant Levels
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A14%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oseltamivir%20and%20Its%20Active%20Metabolite%20Cross%20the%20Placenta%20at%20Significant%20Levels&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Meijer,%20Wouter%20J.&rft.date=2012-06-01&rft.volume=54&rft.issue=11&rft.spage=1676&rft.epage=1677&rft.pages=1676-1677&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/cis265&rft_dat=%3Cjstor_cross%3E23212791%3C/jstor_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c312t-4e1cb3ee1ac43de1c6d346c6477dd661d75ec048a78ee3fb3fb6ea445c02e0ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/22460968&rft_jstor_id=23212791&rfr_iscdi=true